Final programme - eshre 2013

P-461 PGD for monogenic disorders on polar bodies (PBD) - impact of clinical parameters on PBD outcomeA. Hehr, C. Gassner, B. Paulmann, Z. Kowalzyk, M. Klatt, S. Krauß, D. Seifert, B. Seifert, U. Hehr (Germany)P-462 performing PGD+PGS at blastocyst stage rather than only PGD on day-3 does not affect clinical resultsM.G. Minasi, A. Ruberti, A. Biricik, M. Lobascio, D. Zavaglia, M.T. Varricchio, F. Fiorentino, E. Greco (Italy)P-463 does preimplantation genetic screening (PGS) really improve implantation rate? Comparison offrozen-thawed embryo transfers between patients undergoing PGS and those without genetic screeningP. Rubino, S. Bono, R.P. Cotarelo, L. Spizzichino, A. Biricik, A. Colicchia, P. Giannini, F. Fiorentino (Italy)P-464 the potential role of dioxin analogues in prostate cancer and male infertility - preliminary study usingLNCaP cell lineM. Suhorutshenko, K. Rosenstein-Tamm, J. Simm, A. Salumets, M. Metsis (Estonia)Reproductive endocrinologyP-465 rLH supplementation to rfsH during induced ovarian stimulation in the GnRh antagonist protocolimproves implantation and pregnancy ratesA. Nazzaro, A. Salerno, L. Di Iorio, G. Landino, S. Marino, E. Pastore (Italy)P-466 ivf results following transdermal testosterone in poor responders according bologna criteriaF. Fabregues, A. Iraola, G. Casals, M. Creus, S. Peralta, J. Peñarrubia, D. Manau, S. Civico, J. Balasch (Spain)P-467 effects of fsH receptor polymorphismsI. Lindgren, Y. Lundberg Giwercman (Sweden)P-468 Lipid features of polycystic ovary syndrome under different diagnostic criteriaE. Celik, I. Turkcuoglu, B. Ata, A. Karaer, P. Kirici, B. Berker (Turkey)P-469 Comparison of serum Anti-Müllerian hormone levels and affecting factors in polycystic ovary syndromewith and without hyperandrogenismJ. Park, J. Kim, J. Rhee (Korea South)P-470 the role of ethnicity and body weight in determination of AMH levels in women diagnosed withsubfertilityM. Krishnan, O. Rustamov, R. Russel, C. Fitzgerald, S. Roberts (United Kingdom)P-471 Current practice of assessment of ovarian reserve in the UKS. Hapuarachi, B.K. Tan, R.S. Mathur (United Kingdom)P-472 the role of gonadotrophin releasing hormone agonist downregulation in artificially prepared frozenembryo transfer cyclesA. van de Vijver, C. Blockeel, M. Camus, N. Polyzos, L. Van Landuyt, H. Tournaye (Belgium)POSTERSP-473 Combined oral contraceptive use increases serum prostate-specific antigen levels in patients withpolycystic ovary syndromeN. Öztürk Turhan, D. Hizli, Z. Kamalak, A. Kösüs, N. Kösüs, H. Kafali (Turkey)P-474 probability of live birth in women with extremely low anti-Müllerian hormone levelsA. Lukaszuk, M. Kunicki, J. Liss, A. Bednarowska, G. Jakiel, K. Lukaszuk, M. Lukaszuk,B. Olszak-Sokolowska (Poland)Programme book173